Pharma Journalist -

Johnson & Johnson has received approval from the U.S. Food and Drug Administration for its TECNIS PureSee intraocular lens (IOL), a new extended depth of focus (EDOF) lens designed…
Read More...

Vima Therapeutics has announced significant progress in the development of its experimental treatment for movement disorders, revealing that the first patient has been dosed in a Phase…
Read More...

PsiQuantum has announced a new collaborative research agreement with National Cancer Center Japan aimed at advancing the use of utility-scale quantum computing in oncology and…
Read More...

Eli Lilly and Company has issued a public warning about potential safety risks linked to compounded versions of tirzepatide that are being mixed with vitamin B12 and marketed to…
Read More...

Bavarian Nordic has announced an expansion of its strategic collaboration with Serum Institute of India aimed at strengthening global manufacturing capacity for its chikungunya vaccine.…
Read More...

Exclusive Opportunity: Partner With the Leaders Defining the Future of the Digital Lab If your commercial strategy depends on reaching senior R&D leaders who are actively…
Read More...

Idorsia Ltd has entered into an exclusive distribution and commercialization agreement with Pharmalink Drug Store L.L.C to bring its insomnia treatment QUVIVIQ™ (daridorexant) to…
Read More...

Vaccine manufacturer CSL Seqirus has announced a long-term partnership with the Pan American Health Organization (PAHO) Regional Revolving Fund aimed at strengthening influenza vaccine…
Read More...

Danish pharmaceutical company Novo Nordisk has announced a new agreement with telehealth platform Hims & Hers Health aimed at expanding patient access to its FDA-approved…
Read More...

The U.S. Food and Drug Administration has approved an expanded indication for Wellcovorin to treat patients with cerebral folate deficiency linked to variants in the Folate Receptor 1…
Read More...